CASE STUDY:
CSL Behring Launches Mobile App to Improve Treatment Experience for Patients with Rare Diseases
CSL Behring leveraged the BrightInsight Platform to launch a mobile app for adult patients with rare diseases who are taking Hizentra.
Read